By contrast, PD‐L1 expression on CD34+cell subsets in the three triple‐negative MPN patients tested, did not significantly differ from PD‐L1 levels detected on CD34+ cells in healthy controls (Figures 3B and S5B). This evidence concerns the gene CD34 and myeloproliferative neoplasm.